This pathway is associated with CD4+ T cell activation, differentiation, and cytokine secretion implicated in the pathogenesis (46, 47) of and a potential therapeutic target for autoimmune diseases including MS (48). The gene discussed is CD4; the disease is myeloid sarcoma.